Maciej Gręda

Dr. Maciej Gręda


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MJMałgorzata Janeczko-Czarnecka
Małgorzata Janeczko-Czarnecka
MGMaciej Gręda
Maciej Gręda
DCDorota Cichosz
Dorota Cichosz
RŚRobert Śmigiel
Robert Śmigiel
MBMateusz Biela
Mateusz Biela
Background/Objectives: PLA2G6-associated neurodegeneration (PLAN) is an autosomal recessive neurodegenerative spectrum encompassing infantile, juvenile/atypical, and adult-onset phenotypes. Juvenile PLAN may initially resemble autism spectrum disorder or nonspecific developmental regression, delaying diagnosis. Case Presentation: We describe a 14-year-old boy and his 9-year-old sister, both with initially normal early development followed by progressive gait impairment, speech and cognitive regression, epilepsy, contractures, and loss of independent ambulation. Brain MRI in both siblings demonstrated marked symmetric cerebellar atrophy, susceptibility-weighted hypointensity of the globus pallidus and substantia nigra compatible with iron accumulation, and bilateral optic nerve thinning. Electroneurography showed selective motor axonal involvement. Molecular testing identified the same two heterozygous PLA2G6 findings in both children: c.1934G>A (p.Arg645Gln) and an exon 4–7 copy-number gain. Parental testing was unavailable; therefore, the phase of the findings could not be established, and it remains unknown whether they are in trans or in cis. Conclusions: The shared clinical, neuroimaging, and electrophysiological phenotype is strongly consistent with juvenile PLAN and provides additional phenotypic evidence regarding p.Arg645Gln. However, unresolved phase and incomplete structural characterization of the copy-number gain preclude definitive molecular attribution. These cases emphasize the diagnostic value of susceptibility-weighted MRI, deletion/duplication analysis, and family segregation studies in children with progressive neurodevelopmental regression.

16 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
MJMałgorzata Janeczko-Czarnecka
Małgorzata Janeczko-Czarnecka
MGMaciej Gręda
Maciej Gręda
DCDorota Cichosz
Dorota Cichosz
RŚRobert Śmigiel
Robert Śmigiel
MBMateusz Biela
Mateusz Biela
PLA2G6-associated neurodegeneration (PLAN) is an autosomal recessive neurodegenerative spectrum encompassing infantile, juvenile/atypical and adult-onset phenotypes. Juvenile PLAN may initially resemble autism spectrum disorder or nonspecific developmental regression, delaying diagnosis. We describe a 14-year-old boy and his 9-year-old sister, both with initially normal early development, followed by progressive gait impairment, speech and cognitive regression, epilepsy or paroxysmal events, contractures and loss of independent ambulation. Brain MRI in both siblings demonstrated marked symmetric cerebellar atrophy, susceptibility-weighted hypointensity of the globus pallidus and substantia nigra compatible with iron accumulation and bilateral optic nerve thinning. Electroneurography showed selective motor axonal involvement. Molecular testing identified the same two heterozygous PLA2G6 findings in both children: c.1934G>A (p.Arg645Gln), classified as likely pathogenic by the diagnostic laboratory, and a copy-number gain encompassing exons 4–7. Parental testing was unavailable; therefore, the phase of the findings could not be established, and it remains unknown whether they are in trans or in cis. The shared phenotype is highly suggestive of juvenile PLAN. However, unresolved phase and incomplete structural characterization of the copy-number gain preclude confirmation of biallelic PLA2G6 involvement and definitive molecular attribution. These related cases provide a descriptive account of a juvenile PLAN-like phenotype, without independently attributing the phenotype to p.Arg645Gln, establishing variant pathogenicity or a specific genotype–phenotype correlation.